Fanglab:Research: Difference between revisions
Longhou Fang (talk | contribs) No edit summary |
Longhou Fang (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
<div style="padding: 10px; width:820px; margin:0 auto;"> <br/> | <div style="padding: 10px; width:820px; margin:0 auto;"> <br/> | ||
<font size=3> | <font size=3> | ||
'''The Fang lab employ zebrafish and mouse models to studying lipid metabolism in angiogenesis and lymphangiogenesis.''' During his | '''The Fang lab employ zebrafish and mouse models to studying lipid metabolism in angiogenesis and lymphangiogenesis.''' During his postdoctoral studies at UC San Diego, Dr. Fang discovered that apolipoprotein (apoA-I) binding protein (AIBP) | ||
controls angiogenesis via regulation of cholesterol homeostasis.</font><br><br> | controls angiogenesis via regulation of cholesterol homeostasis.</font><br><br> | ||
Revision as of 18:50, 26 March 2017
FANG LABORATORY
The Methodist Hospital Research Institute, Houston, Texas.
You can also visit my homepage at:
Fanglab
The Fang lab employ zebrafish and mouse models to studying lipid metabolism in angiogenesis and lymphangiogenesis. During his postdoctoral studies at UC San Diego, Dr. Fang discovered that apolipoprotein (apoA-I) binding protein (AIBP)
controls angiogenesis via regulation of cholesterol homeostasis.
Based upon the findings, the Fang laboratory will be focusing on the role of AIBP-regulated lipid metabolism in angiogenesis and lymphangiogenesis. We will use a plethora of disease models such as heart hypertrophy, heart ischemia and reperfusion, peripheral artery ischemia and reperfusion, corneal angiogenesis, and tumorigenesis in mice as well as in zebrafish heart regeneration. Both zebrafish and mouse model will be used to study the role of AIBP in lymphangiogenesis.
